Invesco Pharmaceuticals ETF
PJP
110 hedge funds and large institutions have $440M invested in Invesco Pharmaceuticals ETF in 2015 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 38 increasing their positions, 38 reducing their positions, and 7 closing their positions.
86% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 7
17% more call options, than puts
Call options by funds: $1.74M | Put options by funds: $1.48M
5% more funds holding
Funds holding: 105 → 110 (+5)
3% more capital invested
Capital invested by funds: $426M → $440M (+$14.6M)
0% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 38
0.28% less ownership
Funds ownership: 21.99% → 21.72% (-0.28%)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Envestnet Asset Management
Chicago,
Illinois
|
+$5.72M |
| 2 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
+$4.66M |
| 3 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$3.55M |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$3.05M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$2.81M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Summit Capital Management
Seattle,
Washington
|
-$6.96M |
| 2 |
MFS
MSI Financial Services
Springfield,
Massachusetts
|
-$2.82M |
| 3 |
NCM
Niemann Capital Management
Stateline,
Nevada
|
-$2.31M |
| 4 |
KSA
Ken Stern & Associates
San Diego,
California
|
-$2.31M |
| 5 |
AP
Advisors Preferred
Rockville,
Maryland
|
-$2.16M |
PJP Hedge Fund Activity: Q2 2015 in Review
110 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q2 2015, worth a combined $440M — up 3.4% from $426M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new PJP positions and 7 closed out — a net gain of 6 holders — while 38 added to existing stakes and 38 trimmed.
The largest buyer was Envestnet Asset Management, adding an estimated $5.72M. The largest seller was Summit Capital Management, cutting an estimated $6.96M.
- 110 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q2 2015, up from 105 in Q1 2015.
- Funds reported $440M of Invesco Pharmaceuticals ETF stock for Q2 2015, up 3.4% quarter-over-quarter.
- 13 funds opened new Invesco Pharmaceuticals ETF positions in Q2 2015 and 7 closed out, a net change of +6 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q2 2015 was Envestnet Asset Management, an estimated $5.72M added.
- The largest Invesco Pharmaceuticals ETF seller in Q2 2015 was Summit Capital Management, an estimated $6.96M sold.
Based on aggregated 13F filings for Q2 2015.